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Response to Continued Treatment for a Second Year
with Isoniazid Alone or with Isoniazid plus PAS
C. V. RAMAKRISHNAN, A. L. BHATIA, S. DEVADATTA, WALLACE FOX,
A. S. L. NARAYANA, J. B. SELKON & S. VELU
This study from the Tuberculosis Chemotherapy Centre, Madras, summarizes the
progress during the second year of the patients in a concurrent comparison of four domiciIiary
chemotherapeutic regimens (isoniazid plus PAS and three regimens of isoniazid alone) who
had bacteriologically active or bacteriologically relapsed pulmonary tuberculosis, with
isoniazid-resistant organisms, at the end of the first year of treatment.
Of the 57 patients who continued on the same chemotherapy during the second year,
nine had attained bacteriological quiescence by the end ofthat year, 15 still had bacteriolo-
gically active disease and 33 had during the year had a serious radiographic deterioration
necessitating a change of treatment. An association was observed between the response to
treatment in the second year and both the extent of cavi ation and the degree of culture-
positivity at the end of the first year, but no association was found between the response to
treatment in the second year and the level of isoniazid-resistance, the catalase activity, the
susceptibility to hydrogen peroxide or the virulence in the guinea-pig of c ltures solated in
the last months of the first year.
It is concluded that persisting bacteriological positivity at the end of one year’s treatment
with isoniazid, either alone or in combination with PAS, is likely to lead to serious radio-
graphic deterioration, irrespective of th level of isoniazid-resistance or of the catalase
activity of the cultures of tubercle bacilli, and that, consequently, treatment ofpatients with
bacteriologically active pulmonary tuberculosis must aim at rendering the sputum culture-
negative in all instances.
INTRODUCTION
An earlier report from the Tuberculosis Chemo-
therapy Centre, Madras (Tuberculosis Chemotherapy
Centre, 1960) presented the progress in the first
year of all the patients in a controlled comparison of
isoniazid plus p-aminosalicylic acid (PAS) with
three different regimens of isoniazid alone in the
* From the Tuberculosis Chemotherapy Centre, Madras,
India. The Centre is under the joint auspices of the Indian
Council of Medical Research, the Madras State Government,
the World Health Organization and the Medical Research
Council of Great Britain.
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do iciliary treatment of pulmonary tuberculosis.
It w s found that the best treatment in terms of the
attainment of bacteriological quiescence was iso-
n azid plus PAS. A number of authorities believe,
however, that bacteriologically active disease with
isoniazid-resistant tubercle bacilli is not necessarily a
serious state (Deuschle et al., 1954; Middlebrook &
Dressler, 1954; Oestreicher et al., 1955; McDermott.
1960). In view of this, as was pointed out in the
earlier report (Tuberculosis Chemotherapy Centre,
1960), it was important to study the progress over a
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longer period of the patients who had bacteriologi-niazid given in one dose a day. The object of the pre-
cally active disease at 12 months with isoniazid-sent paper is to report the findings for the second year
resistant tubercle bacilli. Further, although two offor all the patients with bacteriologically active or
the isoniazid-alone regimens were clearly unsatis-relapsed disease at one year. The progress in the
factory even in the first year, it is only in the light ofsecond year of the patients whose disease at one
this longer-term study that it is possible finally toyear was bacteriologically quiescent or of doubtful
determine the relative value of the third isoniazid-status has been reported elsewhere (Velu et al.,
alone regimen (HI-1), a moderate dosage of iso-1961).
GENERAL PLAN AND CONDUCT OF THE STUDY
The patients who had bacteriologically active or
relapsed disease (as defined below) at the end of one
year of the initially prescribed chemotherapy con-
tinued on the same regimen for the second year
unless a serious clinical or clear-cut radiographic
deterioration occurred. In this way it was hoped to
discover whether continued chemotherapy with the
same drug or combination of drugs would lead to
quiescence of the disease or whether it was necessary
in such patients to change the chemotherapy-a
point of considerable importance in planning large-
scale campaigns against tuberculosis.
THE CHEMOTHERAPY
The four regimens studied in the first year and
prescribed for the second year for the patients with
bacteriologically active or relapsed disease were:
PH. Isoniazid 3.9-5.5 mg/kg body-weight, plus
PAS (sodium) 0.2-0.3 g/kg, daily, divided into two
doses, by mouth–i.e., 200 mg of isoniazid plus 10 g
of PAS (sodium) a day for a patient weighing 100 lb.
(45.4 kg).
HI-1. Isoniazid alone, 7.8-9.6 mg/kg daily, in
one dose by mouth–i.e., 400 mg of isoniazid a day
for a patient weighing 100 lb.
HI-2. Isoniazid alone, 7.8-9.6 mg/kg daily, divided
into two doses, by mouth–i.e., 400 mg of isoniazid
a day for a patient weighing 100 lb.
H. Isoniazid alone, 3.9-5.5 mg/kg daily, divided
into two doses, by mouth–i.e., 200 mg of isoniazid a
day for patient weighing 100 lb.
The precise dosage scales have been detailed in the
earlier report (Tuberculosis Chemotherapy Centre,
1960). All the patients were treated at home and
were encouraged to remain fully ambulant.
DEFINITION OF BACTERIOLOGICALLY ACTIVE DISEASE
A T  O N E  Y E A R
A patient was considered to have bacteriologi-
cally active disease at one year if the cultures were
never all negative at three consecutive monthly
examinations during the 12-month period (the
patients had, on the average, nearly three specimens
cultured each month).
DEFINITION OF BACTERIOLOGICALLY RELAPSED DISEASE
A T  O N E  Y E A R
A patient was considered to have bacteriologi-
cally relapsed disease at one year if two or more
positive cultures were obtained at the last three
monthly examinations (that is, at 10, 11 and 12
months) after a period of three or more consecutive
months during which all the cultures were negative.
N U M B E R  O F  P A T I E N T S  I N  T H E  S E C O N D - Y E A R  S T U D Y
At the end of one year’s treatment (Table 1) 61
patients who were on the initially prescribed chemo
therapy were classified as having bacteriologically
active or relapsed disease-namely, six (7%) of 
86 PH patients, 12 (19%) of 64 HI-1, 13 (20%) of
66 HI-2 and 30 (35 %) of 86 H patients. In addition,
by that time, two (2%) of the PH patients, five
(8%) of the HI-1 patients, 15 (23 %) of the HI-2
patients and 18 (21%) of the H patients had either
died of tuberculosis or had had their chemotherapy
changed during the first year of treatment because of
serious radiographic or clinical deterioration–
evidence that, even in the first year, the HI-2 and
H regimens were unsatisfactory. Of the 61 patients
who had active or relapsed disease at one year,
three (1 PH, 2 HI-2) did not continue on the initially
pr scribed chemotherapy in the second year as they
had been incorrectly classified at the end of the
year’s treatment on the basis of the then available
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TABLE 1
CLASSIFICATION OF THE PATIENTS AT ONE YEAR ACCORDING TO THEIR RESPONSE TO TREATMENT
Favourable
response
Unfavourable
response
Classification at one year
Bacteriologically quiescent disease
Disease of bacteriologically doubtful status
Bacteriologically relapsed disease
Bacteriologically active disease without
radiographic deterioration
Bacteriologically active disease with
deterioration necessitating a change
of chemotherapy
Tuberculous death
Total patients . . . . . . . . . . . . . .
bacteriological data as having disease that was
bacteriologically quiescent or of doubtful status (all
the culture results were not available at that time).
A further patient (H), who had radiographically
static tuberculous disease and who also had severe
emphysema at 12 months, had his treatment changed
in the thirteenth month on account of cor pulmonale.
There remained 57 patients (5 PH, 12 HI-1, 11 HI-2,
29 H) who had active or relapsed disease at the end
of the first year and continued on the initially
prescribed chemotherapy in the second year.
GENERAL MANAGEMENT AND ROUTINE INVESTIGATIONS
During the second year, the patients attended the
Centre weekly or fortnightly for a supply of their
medicine, and monthly for a routine examination.
This examination included a full-plate postero-
anterior chest radiograph and the examination of a
minimum of one overnight collection specimen of
sputum by smear and culture, or, if no sputum was
being produced, the examination of a pair of laryn-
geal swabs by culture, each on a separate slope; the
two swabs were regarded as a single specimen. A
test of sensitivity to isoniazid was set up on one
positive culture at each month.
COLLAPSE THERAPY AND RESECTION
None of the patients had any form of collapse
therapy or resection during the first or the second
year.
P H HI-1
No. % No. %
74 86 43 6 7
4 5 4 6
4 5 2 3
2 2 10 16
1 1 5 8 14 2 1 15 1 7
1 1 0 0 1 2 3 3
86 100
Treatment series
64 100
HI-2 H
No. % No. %
37 56 38 44
1 2 0 0
5 8 5 6
8 72 25 29
66 101 86 9 9
INDEPENDENT ASSESSMENT OF THE RADIOGRAPHS
Radiographic assessments of the severity of the
disease at 12 months were made from full-plate
postero-anterior radiographs (tomographs were
used for the assessment of the extent of cavitation) by
an independent assessor (Dr Raj Narain) who was
unaware of the treatment the patients had received.
The assessments were: the extent of cavitation,
graded as extensive, moderate, slight or nil; the
total extent of the radiographic lesions, classified as
gross, extensive, moderate, limited, slight, trivial or
nil (Tuberculosis Chemotherapy Centre, 1960); and
the number of lung zones involved in disease, stan-
dar  definitions of zones (Daniels et al., 1948) being
used and the presence of any disease in each zone,
no matter how limited in extent, being recorded.
If, during the course of the second year, a
patient was considered by the Centre’s medical staff
to have a definite radiographic extension of the
disease, the following procedure was adopted. The
supervision of the patient was intensified. A 7- to
10-day course of penicillin was given and a further
radiograph was taken at the end of two weeks or at
the next monthly examination. Careful supervision
for evidence of radiographic evolution of the lesion
was maintained. If the new lesion was persisting or
spreading, and was more than minor, the complete
radiographic series was shown to an independent
asse sor (Dr K. S. Sanjivi) who was unaware of the
treatment the patient was receiving. This pro-
cedure was adopted because of the observation of
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Oestreicher et al. (1955) that the radiographic
spreads which occur under treatment with isoniazid
alone frequently resolve without a change of
chemotherapy. The assessor sometimes decided
that the disease had deteriorated radiographically
to such an extent that chemotherapy should be
changed. In other instances, he considered a change
of chemotherapy was not warranted and indicated
if and when he wished to see the radiographic series
again. In addition, serious clinical deterioration was
regarded as a reason for changing the chemotherapy
without reference to an independent assessor. At
the end of two years the full radiographic series of
all the patients who continued on the initially pres-
cribed regimen until that time and who still had
bacteriologically active disease were reviewed by
the independent assessor to ensure that all the
radiographic spreads warranting a change of treat-
ment had been detected.
DEFINITION OF BACTERIOLOGICAL QUIESCENCE
A T  T W O  Y E A R S
A patient’s disease was classified as bacterio-
logically quiescent at the end of the second year
if not more than one of the specimens examined at
the last six monthly examinations was positive on
culture.
BACTERIOLOGICAL METHODS
Examination of sputum specimens and laryngeal
swabs ; sensitivity tests
The methods used for examining sputum speci-
mens and laryngeal swabs and for determining the
sensitivity of cultures to isoniazid have been
described in detail elsewhere (Tuberculosis Chemo-
therapy Centre, 1959, 1960). In brief, tests of
sensitivity to isoniazid were performed by inocula-
ting a 3-mm diameter loopful of a 4 mg/ml (moist
weight) aqueous suspension of growth from a
Löwenstein-Jensen medium culture on to a slope of
this medium without isoniazid and on to a series of
slopes containing 0.2, 1, 5 and 50 µg/ml of isoniazid.
The degree of growth was recorded after four
weeks’ incubation at 37°C. The minimal inhibitory
concentration (MIC) of isoniazid was defined in
two ways-namely, as the lowest concentration of
isoniazid that prevented the growth of 20 colonies
or more (the 20-colony MIC) and as the lowest con-
centration of isoniazid that prevented an equal
amount of growth to that on the drug-free control
slo e (the equal-growth MIC). The patients were
classif ed according to the level of resistance to
isoniazid of the majority of the cultures isolated at
10, 11 and 12 months which were tested for their
sensitivity to isoniazid. If no majority could be
btained, as, for example, when there were only two
cultures and they gave different results, then the
resul  of the culture isolated at nine months was
includ d. As shown in Table 2, patients were
classified according to the 20-colony definition
as having harboured organisms with “ very high ”
resistance if the majority of the cultures had MICs
which were greater than 50 µg/ml, with “high ”
resistance if the majority of the MICs were 50 µg/ml,
with “ moderate ”resistance if the majority of the
MICs were 5 µg/ml and with “ low ” resistance if the
majority of the MICs were 1 µg/ml. The classifica-
tion of the patients according to the equal-growth
MIC was the same (Table 2), but included an
additional category of “ sensitive ” for those
patients who had a majority of cultures with MICs
of 0.2 µg/ml or less-that is, where the growth on
0.2 µg/ml was less than that on the control slope.
Catalase activity
The catalase activity of the cultures tested for
their sensitivity to isoniazid was determined by the
semiquantitative method described by Kreis, Le
Joubioux & Pariente (1956). In brief, a suspension
of the growth (approximately 4 mg moist weight)
was exposed to contact with a 0.3 % (w/v) aqueous
solution of hydrogen peroxide at pH 7 for one hour
at 8°C. After the addition of 0.5 ml of N sulfuric
acid the residual peroxide was estimated by titration
with potassium permanganate. The catalase acti-
vity was expressed as the percentage of the peroxide
destroyed (to the nearest 10%).
Susceptibility to hydrogen peroxide
The susceptibility of the cultures to hydrogen
peroxide was determined by the method described
by Subbaiah, Mitchison & Selkon (1960). In brief,
cultures were exposed to 0.02% (w/v) hydrogen
peroxide in pH 7 buffer solution for 90 minutes and
the proportion of the population which survived was
determined by viable counting. The susceptibility
to hydrogen peroxide was expressed as the propor-
tion of the population of organisms tested which
survived this exposure.
Virulence of tubercle bacilli in the guinea-pig
The virulence of cultures of tubercle bacilli in the
gui ea-pig was measured by inoculating intra-
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TABLE 2
CLASSIFICATION OF THE PATIENTS ACCORDING TO THE LEVEL OF RESISTANCE TO ISONIAZID
OF THE CULTURES ISOLATED AT 10, 11 AND 12 MONTHS
5
I 20-colony MIC 
a of isoniazid (µg/ml) b I Equal-growth MIC 
a of isoniazid (µg/ml)Classification
of the level
of isoniazid-
resistance 1 > 5 0
3
2
1 c
2 d
1
1
3
2
1
2
1
1
1
50
1
3
2
2
2 d
1
Number of  
patients   
7
3
2
1
2
1
3
1
2
1
1
2
2
        50
Number of
patients
10
3
4
6
> 50
3
2
2
2
2
< 0.2
1 
Very high
1
High
3
2
1 
c
2
2
2 d
2 d
1C
1
1
Moderate
1 c
1
2
1
        Low
“ Sensitive ”
a Minimal inhibitory concentration.
b The figures in each column under the MIC denote the number of culture results per patient.
c 9-month culture result.
d Including a 9-month culture result for one patient.
muscularly 1.0 mg (moist weight) of the cultureliver, lungs and local glands was assessed as a score
into each of two guinea-pigs, one of which wasranging from 0 to 100. The square-root of the ratio
killed at 6 weeks and the other at 12 weeks, unless itof the score to the survival period in days was
had already died. At post-mortem examination,de ermined for each guinea-pig (whether sacrificed
the total extent of tuberculous disease in the spleen,or d ad from tuberculosis), and was termed the
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root-index. The measure of virulence employedments, the larger at the Microbiological Research
was the mean of the root-indices for the two guinea-Establishment, Porton, England, and the smaller
pigs inoculated with each culture, and was termedat the Centre in Madras; the results of the Madras
the root-index of virulence (Mitchison et al., 1961).series were adjusted to those obtained at Porton as
The virulence tests were done in two series of experi-d scribed by Mitchison et al. (1962).
RESULTS
The progress during the second year of the 61
patients who were classified as having had bacterio-
logically active or relapsed disease at 12 months will
be presented in two sub-sections. The first reports on
the 57 patients who continued on the originally
prescribed chemotherapy in the second year and the
second on the three patients who, in error, had their
chemotherapy changed at one year and on the
patient who had his treatment changed on account
of cor pulmonale.
PROGRESS IN THE SECOND YEAR OF THE PATIENTS WHO
CONTINUED ON THE ORIGINALLY PRESCRIBED
CHEMOTHERAPY
Response to treatment
The progress in the second year of the 57 patients
with bacteriologically active or bacteriologically
relapsed disease at one year who continued on the
originally prescribed chemotherapy is set out in
Table 3. One (HI-2) of the 57 patients insisted on
having his treatment changed at 18 months, at which
time he still had consistently positive cultures with
radiographically static disease. Despite a change to
streptomycin plus PAS his cultures remained positive
up to and including 21 months. This patient has
been classified in Table 3 and in all the analyses as
having active disease without radiographic deteriora-
tion at two years. Bacteriological quiescence was
achieved in nine of the 57 patients-namely, one of
five PH patients, two of 12 HI-1, one of 11 HI-2 and
five of 29 H patients. The month at which the last
positive culture was obtained was the twelfth month
for the PH patient, the tenth month for one of the
HI-1 patients and the eleventh month for the other
(apart from isolated positive cultures at 15 and 24
months), the twelfth month for the HI-2 patient
(apart from an isolated positive culture with l-colony
growth at 17 months) and the tenth, tenth, eleventh,
eleventh and thirteenth months, respectively, for the
five H patients. Thus, all except three of the patients
who attained bacteriological quiescence during the
second year had already converted their sputum to
bacteriological negativity late in the first year; and
the exceptions did so very early in the second year.
All the patients who were bacteriologically positive
at 14 months either had active disease for the rest of
the period or else deteriorated radiographically to 
an extent that warranted a change of treatment.
Fifteen patients (1 PH, 3 HI-1, 6 HI-2, 5 H) had
active disease throughout the second year but with-
out definite radiographic deterioration (Table 3).
Radiographic deterioration, warranting a change of
treatment, occurred in 33 patients (3 PH, 7 HI-1,
4 HI-2, 19 H). The month in which the deterioration
occurred ranged from the thirteenth to the twenty-
fourth (Table 3).
Bacteriologically quiescent disease was attained by
the d of the second year by five (8%) of the
43 patients classified as having active disease at one
year, and by four (35%) of the 14 patients with
relapsed disease at one year. The proportions of
patients whose disease deteriorated in the second
year was similar for those with active and with
relapsed disease at one year.
In summary, of the 57 patients, nine (16%)
attained bacteriological quiescence, 15 (26 %) still
had active disease at two years and 33 (58%) had
deteriorated radiographically to an extent which 
warranted a change of treatment. There were no
important differences between the response to
treatment in the four treatment series.
Sensitivity to isoniazid of cultures isolated during the
second year
Tests of sensitivity to isoniazid were done on 257
of the positive cultures isolated from the 57 patients
during the second year. Of these cultures, 255 were
resistant to isoniazid (growth of 20 colonies or more
on 0.2 µg/ml or a higher concentration) and two
(0.8 %) were sensitive. These two cultures were from
a PH and an H patient and were isolated sensitive
cul ures among a series of six and seven resistant
cultures, respectively. These observations confirm
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T A B L E  3
R E S P O N S E  T O  T R E A T M E N T  I N  T H E  S E C O N D  Y E A R  O F  T H E  P A T I E N T S  W H O  H A D  B A C T E R I O L O G I C A L L Y  A C T I V E  O R
RELAPSED DISEASE AT ONE YEAR AND WHO CONTINUED ON THE INITIALLY PRESCRIBED CHEMOTHERAPY
Status of the disease at two years
Radiographic deterioration
warranting a change of treatmentNumber of
patients
Bacteriologically quiescent
Month at which
Bacterio-Treatmentseries
Disease status
at one year
--
Active
Relapsed
Total
Active
Relapsed
Total
Active
Relapsed
Total
Active
Relapsed
Total
Number Month of deterioration
2 16, 24
1 21
3 –
P H
5  1    –    1
HI-1
6 13, 15, 18, 18, 18, 20
1 20
I -
I
12 2  –  3
7 0 -  5
4 1 12 1
11  1 –  6
24 4 10, 10, 11,13 5
5 1 11 0
29  5 –  5
43  5 – 13
14 4 –
HI-2
4 –
15
4 13, 16, 17, 24
H
19 –
I
Active
Relapsed
Total patients
25 –
8 –All series
57 9 – 15 33                    –
that the strains which the patients were excreting
were consistently isoniazid-resistant.
Response in the second year related to radiographic
and bacteriological assessments at the end of th
first year
Extent of cavitation. Bacteriologically quiescent
disease was attained by 23 % of 35 patients with no or
slight cavitation at 12 months, but by only 5 % of
22 patients with moderate or extensive cavitation at
one year (Table 4). However, this difference fails to
attain significance (P = 0.07). Deterioration war-
ranting a change of treatment occurred in 33% of 21
patients without cavitation at 12 months, as com-
pared with 72% of 36 who had cavitation, a signifi-
cant difference (P = 0.01). Considering only the
patients whose disease did not attain bacteriological
quiescence, deterioration occurred in 47 % of 15
patients with no cavitation and in 79% of 33 with
cavitation at one year, a difference that also attains.
significance (P = 0.05).
Number of lung zones involved in disease. Bacterio-
logically quiescent disease was attained by 27% of
22 patients with two or fewer lung zones involved in
disease at 12 months, as compared with 9% of 35
patients with three or more lung zones involved;
while 50% of 22 patients with two or fewer lung zones
involved in disease deteriorated to an extent which
warranted a change of treatment, as compared with
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T A B L E  5
R E S P O N S E  T O  T R E A T M E N T  I N  T H E  S E C O N D  Y E A R
RELATED  TO  THE  NUMBER  OF  LUNG ZONES
I N V O L V E D  I N  D I S E A S E  A T  O N E  Y E A R
T A B L E  4
R E S P O N S E  T O  T R E A T M E N T  I N  T H E  S E C O N D  Y E A R
R E L A T E D  T O  T H E  E X T E N T  O F  C A V I T A T I O N
A T  O N E  Y E A R
Status of  the disease us of the
at two years
  B
l
No. %
1
0
2
2
5 ( 2 3 )
Stat
P a t i e n t s Bacterio-
logically
q u i e s -
c e n t
No. % N o .  %
4 1
2 1
6 1
10 3
2 2  1 0 0
II series 18 1 0 1
0
4
3
10
1 7  1 0 0
6 (27)a
0
1
0
0
1 (6) 
0
0
0
2
2 ( 1 2 )
disease
Radio-
graphic
deteriora-
tion war-
ranting a
change of
treatment
No. %
2
1
3
5
11 (50)
1
3
1
7
12 (67)
0
3
0
7
10 (59)
at two years
Bacterio-
logically
quies-
cent
N o .  %
1
1
1
3
N o .  %
1
1
4
2
6 (29)a 8 ( 3 8 )
0 0
0 0
0 0
2 2
Radio-
graphic
deteriora-
tion war-
ranting a
change of
treatment
No. %
0
1
3
3
7 (33)
1
2
1
6
10 (71)
2
2
0
8
12 (67)
0
2
0
2
4 (100)
33 58
Number of
lung zones
involved
in disease
at one year
0, 1 or 2
Treat-
ment
se r i e s
P H
HI-l
HI-2
H
 lI series
PH
HI-1
HI-2
H
P H
HI-1
HI-2
H
 ll series
Extent off Treat-
cavitation ment
at one year series
Nil
Slight
P H
HI-1
HI-2
H
Patients
N o .  %
2
3
8
6
21 100 ll series
P H
HI-1
HI-2
H
3
5 ( 2 8 ) ll series 2 ( 1 4 ) 2 ( 1 4 )14 9 9
2
5
2
9
P H
HI-1
HI-2
H
0
1
0
2
0 2
0  1
Moderate 4 or 5
All series 18 1 0 1 1 ( 6 ) 5 ( 2 8 )
0 ( 0 )
9 1 6 1 5 2 6
5 7  1 0 0 9 1 6 15 2 6 33 5 8P H
HI-1
HI-2
H
T o t a l  p a t i e n t s
aThe parentheses indicate percentages based on fewer
than 25 observations.
Extensive
disease at two years and the over-all radiographic
extent of the disease at 12 months (Table 6). How-
ever, it will be noted that none of the four patients
whose extent of disease at 12 months was classified
as slight, trivial or nil deteriorated during the second
year, as compared with 61% of 33 patients with
limited disease and 65 % of 20 patients with moderate
or extensive disease.
 ll series 4 1 0 0
57 1 0 0T o t a l  p a t i e n t s
a The parentheses indicate percentages based on fewer
than 25 observations.
63 % of 35 with three or more lung zones involved
(Table 5). However, neither of these differences
attains statistical significance.
Total extent of disease. There was no clear evi-
dence of any association between the status of the
Degree of culture-positivity. The patients were
classified, on the basis of a scoring system, according
to the degree of growth on culture of all their sputum
and laryngeal swab specimens examined at 10, 11
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R E S P O N S E  T O  T R E A T M E N T  I N  T H E  S E C O N D  Y E A R
R E L A T E D  T O  T H E  T O T A L  E X T E N T  O F  D I S E A S E
A T  O N E  Y E A R
R E S P O N S E  T O  T R E A T M E N T  I N  T H E  S E C O N D  Y E A R
R E L A T E D  T O  T H E  M E A N  S C O R E  F O R
CULTURE-POSITIVITY AT 10,  11 AND 12 MONTHS
Patient
N o .  %
Status of the disease
at two years
 R a d i o -
Bacterio-
logically
quies-
cent
N o .  %
0
0
0
2
graphic
Bacterio- deteriora-
Iogically tion war-
ranting a
change of
treatment
N o .  % No. %
Status of the disease
at two years
Radio-
graphic
- deteriora-
   tion war-
ranting a
change of
treatment
- / N o .No.       %            No.       %
Total
extent Treat-ment
of disease                            
at one year series
Patients
N o .  %
1
0
1
2
4 1 0 0
1
5
9
18
13 1 0 0
3
7
1
9
20 1 0 0
i
17 1 0 0
0.0-
P H
HI-l
HI-2
H
1  0
3 ( 3 8 )
0 0
1 0
0 0 9 1 0 0
2
0
1
5
6 (67)a 1 ( 7 1 )All series
P H
HI-1
0.5- HI-2
 H
All  series
P H
HI-1
L i m i t e d  HI-2
 H
All  series
8 1 0 1 2 (25)  3 ( 3 8 )All series
        PH
      HI-1
1
3
1
1
6 ( 8 6 )
1
2
1
8
12 ( 8 0 )
1
0
0
6 b
7 ( 6 4 )
9 27 20 6 1
0 (0)  1 ( 1 4 )All seriesP H
HI-1
1.5-
P H
HI-I
HI-2
H
M o d e r a t e  HI-2
or
extensive H
‘All series 3 ( 1 5 ) 4 (20) 13 ( 6 5 )
7 1 0 0 1 (14)  3 ( 4 3 )All series
P H
HI-1
2.0- HI-2
 H
9 1 6Total patients . . . 15 26 33 5 8
a The parentheses indicate percentages based on fewer
than 25 observations.
All series 0 (0)  3 ( 2 0 )
l and 12 months (an average of seven to nine cultures).
A score of 4 was given for a 3-plus positive culture
(confluent growth), 3 for a 2-plus positive culture
(innumerable discrete colonies), 2 for a 1-plus
positive culture (100-20 colonies), 1 for the presence
of 19 to 1 colonies and 0 for a negative culture. The
mean score for each patient was calculated and the
findings are set out in Table 7. Of the 17 patients
who had mean scores of less than 1.0, 47 % attained
bacteriological quiescence during the second year,
as compared with 2% of the 40 patients who had a
mean score of 1.0 or more, a highly significant dif-
ference (P < 0.001). Conversely, only 29% of the
2.5-2.9
P H
HI-1
HI-2
H
All series 0 (0)  4 ( 3 6 )
T o t a l  p a t i e n t s 57 1 0 0 9 16  15 2 6 33 5 8
0.5  1.8 1 .8Mean scor  for culture-positivity  
aThe parentheses indicate percentages based on fewer
than 25 observations.
b Including one patient with a mean score of 3.1.
10 C. V. RAMAKRISHNAN AND OTHERS
17 patients who had mean scores of less than 1.0
deteriorated to an extent that warranted a change
of treatment, as compared with 70% of the 40
patients who had mean scores of 1.0 or more; this
difference also attains significance (P = 0.01). This
finding that the response to treatment in the second
year was related to the degree of culture-positivity in
the last three months of the first year must be inter-
preted with caution, for it will be appreciated that,
as already mentioned (page 6), 67% of the nine
patients who attained bacteriological quiescence had
already started to yield negative cultures before the
end of the first year. Furthermore, considering only
the patients who did not attain quiescence by the end
of the second year, 56% of nine patients with
positivity scores of less than 1.0 deteriorated to an
extent that warranted a change of treatment, as
compared with 72% of 39 with scores of 1.0 or more,
a difference which does not attain statistical signifi-
cance.
Since there was an association between the attain-
ment of bacteriological quiescence by the end of the
second year and both the extent of cavitation and the
degree of culture-positivity at the end of the first
year, the prognostic value of a combination of these
two assessments was studied. Of the 12 patients
without cavitation who had culture-positivity scores
of less than 1.0, six attained quiescence, three
remained bacteriologically active and three deterio-
rated during the second year. Thus, a combination
of these two assessments was of no greater prog-
nostic value than culture-positivity alone.
In summary, the response of the patients during
the second year was related to the extent of cavita-
tion and to the degree of culture-positivity, but only
to a minor extent, if at all, to the number of lung
zones involved or the total extent of disease at the
end of the first year.
Level of  isoniazid-resistance :
(a) 20-colony MIC. Patients were classified (see
page 4) according to the level of isoniazid-resis-
tance (20-colony definition) of the cultures at 10, 11
and 12 months. This classification is related to the
response to treatment in the second year in Table 8.
Of the 42 patients with cultures of very high or high
resistance to isoniazid, 14 % attained bacteriological
quiescence, as compared with 25% of 12 patients
with cultures of moderate resistance and none of
three with cultures of low resistance. There was a
suggestion that a larger proportion of deteriorations
occurred in the patients with cultures of high or very
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R E S P O N S E  T O  T R E A T M E N T  I N  T H E  S E C O N D  Y E A R
RELATED TO THE LEVEL OF ISONIAZID-RESISTANCE
Level of
isoniazid-
resistanc
(20-colony
MIC) at the
end of the
first year a
Very high
High
Low
A T  T H E
C O R D I
P H
HI-1
HI-2
H
 II series
P H
HI-l
HI-2
H
 II series
P H
HI- l
HI-2
H
 ll series
P H
HI-1
HI-2
H
 lI series
Total patients . . .
E ND OF THE FIRST YEAR,
NG  T O  T H E  2 0 - C O L O N Y  M I C
Patients
N o .  %
1
3
7
12
23 1 0 0
1
5
3
10
1 9  1 0 0
12 1 0 0
1
1
0
1
3 1 0 0
57 1 0 0
 
I
Stat
Bacterio-
logically
quies-
cent
- -
N o .  %
1
1
1
3
6 ( 2 6 )b
us of the disease
at two years
Radio-
graphic
 Bacterio- deteriora-
Iogically  tion war-
ranting a
change of
treatment
9 1 6
No. %  No. %
0  0
1 1
4 2
1 8
6 (26) 11 ( 4 8 )
0 1
1 4
1 2
1 9
3 (16) 16 ( 8 4 )
1 1
0 2
1 0
2 2
4 (33) 5 ( 4 2 )
0 1
1 0
0 0
1 0
2 ( 6 7 ) 1 ( 3 3 )
15 26  33 58 
a For definitions, see page 4.
b The parentheses indicate percentages based on fewer
than 25 observations.
high resistance (64% of 42) than in patients with
cultures of moderate or low resistance (40% of 15).
However, this difference does not attain significance
(P ~ 0.2). Thus, there was little evidence that pro-
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gress during the second year was related to the level
of isoniazid-resistance (20-colony definition) at the
end of the first year of treatment.
(b) Equal-growth MIC. Table 9 relates the response
to treatment in the second year to the classification
of the patients according to the equal-growth defini-
tion of isoniazid-resistance. Considering the 45 pa-
tients with cultures of moderate or higher degree of
resistance, 18% had quiescent diease at two years,
18 % remained bacteriologically active and 64 % had
deteriorated to an extent that warranted a change
of treatment. In comparison, of the 12 patients with
low resistance or “ sensitive ” cultures, the cor-
responding figures were 8%, 58% and 33%, respect-
ively. Thus there was little evidence that the progress
of the patients during the second year was related
to the level of resistance (equal-growth definition) of
the cultures isolated at the end of the first year.
It remained a possibility that an association
between the response to treatment in the second year
and the level of resistance to isoniazid at one year
was present, but that it was obscured in the above
analyses by the other prognostic factors. Analyses
(not tabulated here) were therefore undertaken to
examine the relationship between response to treat-
ment and the level of resistance according to both
the 20-colony and the equal-growth definitions of the
MIC, after stratifying the patients according to the
extent of cavitation and according to the degree of
culture positivity at the end of the first year. No
clear associations between response to treatment and
the level of resistance were observed.
Catalase activity. Table 10 relates the response to
treatment in the second year to the mean catalase
activity (semiquantitative method) of the cultures
isolated during the last three months of the first year.
There were 17 patients with strains with no, or very
low, catalase activity (0-19%) and of these 24%
attained bacteriological quiescence, 24% remained
bacteriologically active and 53 % had a deterioration
warranting a change of treatment. There were 15
patients whose strains had a catalase activity of
20-29 %, and of these 13 % attained bacteriological
quiescence, 33 % remained bacteriologically active
and 53 % had a deterioration warranting a change of
treatment. Considering catalase activity of 30-49 %,
27% of 11 patients attained bacteriological quies-
cence, 9 % remained bacteriologically active and 64 %
deteriorated. Of the 14 patients with strains of high
catalase activity (50% or more), none attained
bacteriological quiescence, 36 % remained bacterio-
T A B L E  9
R E S P O N S E  T O  T R E A T M E N T  I N  T H E  S E C O N D  Y E A R
RELATED TO THE LEVEL OF ISONIAZID-RESISTANCE
A T  T H E  E N D  O F  T H E  F I R S T  Y E A R ,  A C C O R D I N G  T O
D U A L - G R O W T H  M I CT H E
Treat-
ment
series
P H
HI-1
HI-2
H
II series
P H
HI-1
HI-2
H
II series
P H
HI-l
HI-2
H
II series
P H
HI-1
HI-2
H
II series
P H
HI-1
HI-2
H
El
A
A
A
A
A
Status of the disease
at two years
I  R a d i o -
- Patients Bacterio
logically
quies-
cent
- -
No. % No. %
18 100 3 (17)
Very high
High
Moderate
Low
“Sensitive’
16 1 0 0
1
3
1
5
1 0  ( 6 2 )
1 ( 2 0 )
33 5 8
 
7 1 0 0
1
1
1
2
1 (20)  3 ( 6 0 )II series                  5         100  
9 16  15 2 6Total patients  . . .  57 1 0 0
a For definitions, see page 4.
b The parentheses indicate percentages based on fewer
than 25 observations.
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TABLE IO
R E S P O N S E  T O  T R E A T M E N T  I N  T H E  S E C O N D  Y E A R
R E L A T E D  T O  T H E  M E A N  C A T A L A S E  A C T I V I T Y  O F
THE CULTURES AT 10, 11 AND 12 MONTHS
active and 34% for those who deteriorated. There
is, thus, a slight suggestion that patients who had
cultures with high catalase activity less frequently
attained bacteriological quiescence than those who
had cultures with lower catalase activity. However,
the difference between the mean catalase activity of
the cultures from the patients who attained quies-
cence and that of the cultures from those who
remained bacteriologically active or who deteriorated
does not attain significance (P ~ 0.1). The catalase
activity of cultures was also estimated from the
amount of gas liberated after immersion of a loopful
of growth in a solution of hydrogen peroxide
(qualitative method of Tuberculosis Chemotherapy
Centre, 1959). The conclusions from the analysis of  
the results obtained by this method were very
similar to those presented above for the semi-
quantitative method.
The slight association between the attainment of
bacteriologically quiescent disease and low catalase
activity was also seen, though it did not attain
significance, when the patients were stratified accord-
ing to the extent of cavitation, but it was not apparent
when they were stratified according to the degree of
culture-positivity. This association was thus mainly
a reflection of an association between catalase
activity and the degree of culture-positivity at the
end of the first year.
Isoniazid-resistant strains of tubercle bacilli which
have high levels of resistance to isoniazid and low
catalase activity are less virulent in the guinea-pig
than strains with low levels of resistance and high
catalase activity (Cohn et al., 1954; Mitchison, 1954;
Freerksen & Meissner, 1956). It is therefore of
particular interest to compare the response to treat-
ment of patients who harboured these different
types of isoniazid-resistant strains.Of the 16 patients
who had cultures with both high or very high resist-
ance to isoniazid according to the 20-colony MIC
and a mean catalase activity of less than 20%, 19%
had attained bacteriological quiescence by the end of
the second year, 25% remained bacteriologically
active and 56% had deteriorated to an extent that
warranted a change of treatment. This is fairly
similar to the response to treatment of the 14
patients who had cultures of moderate or low
resistance and 20% or higher catalase activity, for
14% attained bacteriological quiescence, 43%
remained bacteriologically active and 43% deterio-
rated.
Considering the equal-growth MIC, of the 13
patients who had cultures with high or very high
us
at
 o f  t h e
 two ye
Bacterio
logically
active
N o .  %
0
1
2
1
 dis
ars
-
e a s e
Radio-
graphic
deteriora-
tion war-
ranting a
change of
treatment
No. %
9 (53)
1
1
1
5
8 (53)
1
3
0
3
7 (64)
1
2
1
5
9 (64)
33 58
34 %
Mean
catalase
activity a
10, 11 an
12 month
(%)
O-19
30-49
50 or more
Bacterio-
logically
quies-
cent
No. %
0
0
1
3
4 (24) ’
3 ( 2 7 )
Treat-
ment
series
P H
HI-1
HI-2
H
Patients
N o .  %
0
2
5
10
17 1 0 1
3
2
3
7
15 9 9
1
5
1
4
11 1 0 0
1
3
2
8
t
d
s
 
 ll series
P H
HI-1
HI-2
H
1
1
2
1
5 ( 3 3 )
- -
0
0
1
0
 ll series
P H
HI-1
HI-2
H
All series
P H
HI-1
HI-2
H
AII series 14 1 0 0
9 1 6T o t a l  p a t i e n t s
Mean catalase activity  . . .
aThe parentheses indicate percentages based on fewer
than 25 observations.
logically active and 64% deteriorated. The ea
catalase activity for the patients who attained
bacteriological quiescence was 21%, as compared
with 34% for those who remained bacteriologically
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resistance and also less than 20% catalase activity,
23 % attained bacteriological quiescence, 15 %
remained bacteriologically active and 62% deterio-
rated. This is not very different from the response of
the 24 patients who had cultures with moderate or
low resistance or “ sensitive ” organisms and 20 % or
higher catalase activity, for 8 % attained bacterio-
logical quiescence, 33 % remained bacteriologically
active and 58% deteriorated. There is, thus, no
evidence that cultures with very high isoniazid-
resistance and little or no catalase activity were less
virulent in patients than cultures with moderate or
low resistance and greater catalase activity.
   Susceptibility to hydrogen peroxide. Of the 57
patients, 35 had cultures obtained late in the first
year which were tested for their susceptibility to
hydrogen peroxide (Table 11). The cultures were
isolated from 27 of these patients at 12 months, from
one at 11 months and from seven at nine months.
Of the 13 patients who had cultures of which
less than 0.0001% of the tubercle bacilli survived
exposure to hydrogen peroxide, 15% attained
bacteriological quiescence, 15 % remained bacterio-
logically active and 69% deteriorated. The cor-
responding figures for the 22 patients who had
cultures of which 0.0001% or more of the tubercle
bacilli survived exposure were 5 %, 41% and 55 %,
respectively.There was, thus, no association
TABLE  I I
R E S P O N S E  T O  T R E A T M E N T  I N  T H E  S E C O N D  Y E A R
R E L A T E D  T O  T H E  S U S C E P T I B I L I T Y
TO  HYDROGEN PEROX IDE  OF  CULTURES
I S O L A T E D  A T  T H E  E N D  O F  T H E  F I R S T  Y E A R
Proportion of
viable units
which survived
exposure to
hydrogen
peroxide
(%)
Less than 0.0001
0.0001-
0.01-
1.0 or more
Total patients . .
Status of the disease at two years
13 99 2 (15)a 2 (15) 9 (69)
7 100 0 (0) 2 (29) 5 (71)
7 100 1 (14) 3 (43) 3 (43)
8 100 0 (0) 4 (50) 4 (50)
35 100 3 9 11 31 21 60
I
aThe parentheses indicate percentages based on fewer
than 25 observations.
between response to treatment and the susceptibility
of the cultures to hydrogen peroxide.
Virulence in the guinea-pig. Of the 57 patients, 52
had cultures obtained late in the first year which were
tested for virulence in the guinea-pig, the cultures
being isolated from 43 at 12 months, from two at 11
months and from seven at nine months. The res-
ponse to treatment in the second year is related to the
root-index of virulence in Table 12.
TABLE 12
R E S P O N S E  T O  T R E A T M E N T  I N  T H E  S E C O N D  Y E A R
R E L A T E D  T O  T H E  V I R U L E N C E  I N  T H E  G U I N E A - P I G  O F
CULTURES ISOLATED AT THE END OF THE FIRST YEAR
Root-ind x
of virulence
of 9-, 11- or
12-month
culture
0.0-
0.9
or above
Status of the disease
Treat-
ment
series
Patients Bacterio
logically
quies-
cent
No. % No. %
P H 2 1
HI-1 6 2
HI-2 5 0
H 19 2
All series 32 1 0 1
P H 2
HI-1 6
HI-2 5
H 4
All series 17 1 0 0
PH 0
HI-1 0
HI-2 0
H 3
All series  3  1 0 0
Total patients . . .     52 b 100
Mean root-index of virulence
5 1 6
5 16
22 6 9
1 ( 6 )a 8 ( 4 7 ) 8 (47)
t two year
Bacterio-
logically
active
S
Radio-
graphic
deteriora-
tion war-
ranting a
change of
treatment
No. %
1
3
3
15
1 (33) 0 ( 0 ) 2 (67)
7 13 13 2 5 32 62
0 . 4 7  0.62 0.53
a The parentheses indicate percentages based on fewer
than 25 observations.
b Excluding five patients (1 PH, 1 HI-2, 3 H) who did not
have virulence tests done on their 9-, 11- or 12-month culture.
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Of the 32 patients who had cultures with a root-
index of virulence of less than 0.60, 16 % had attained
bacteriological quiescence by the end of the second
year, 16% were bacteriologically active and 69%
had deteriorated to an extent warranting a change of
treatment. The corresponding proportions for the
17 patients who had cultures with a root-index of
virulence between 0.60 and 0.89 were 6 %, 47 % and
47%. The mean root-index of virulence of the
cultures from the seven patients who attained
bacteriological quiescence was 0.47, from the 13
patients who remained bacteriologically active was
0.62 and from the 32 patients who had deteriorated
was 0.53. Thus, there was little association between
the response to treatment in the second year and the
root-index of virulence of the cultures isolated at the
end of the first year.
PROGRESS IN THE SECOND YEAR OF THE FOUR PATIENTS
W H O  H A D  T H E I R  T R E A T M E N T  C H A N G E D  A T  T H E  E N D
O F  T H E  F I R S T  Y E A R
Considering the three patients who, in error, did
not continue on their initially prescribed chemo-
therapy, one (HI-2) received 200 mg of isoniazid
daily and two (1 PH, 1 HI-2) received 500 mg of the
placebo, calcium gluconate, daily. The HI-2 patient
who received isoniazid yielded negative cultures
throughout the second year, the last positive culture
having been obtained at the eleventh month. At the
end of the first year he had slight cavitation, a
culture-positivity score of 0.1, and his cultures had
very high resistance according to the 20-colony
definition, moderate resistance according to the
equal-growth definition, 0% catalase activity and a
root-index of virulence of 0.57. The two patients
who received the placebo had bacteriologically
active disease at two years, but without evidence of
deterioration. At the end of the first year the PH
patient had moderate cavitation, a culture-positivity
score of 0.3, moderate resistance according to both
the 20-colony and equal-growth definitions, 30%
catalase activity and a root-index of virulence of
0.36. The corresponding findings for the HI-2
patient were slight cavitation, a culture-positivity
score of 0.2, moderate resistance according to both
efinitions, 35% catalase activity and a root-index
of virulence of 0.54.
The H patient (see page 3) who had his treat-
m nt changed in the thirteenth month because of
severe cor pulmonale, but who showed no evidence
f deterioration of the tuberculosis, received strepto-
mycin and PAS until his death from cardiac failure in
the fifteenth month. His sputum remained culture-
positive during the thirteenth and fourteenth months.
At the nd of the first year he had slight cavitation, a
cultur -positivity score of 2.3 and had cultures with
very high resistance according to the 20-colony  
efinition, moderate resistance according to the
equal-growth definition, 13 % catalase activity and
a root-index of virulence of 0.53.
OCCURRENCE OF DRUG-TOXICITY DURING
THE SECOND YEAR
In the first year one (1%) of 90 PH, 13 (19 %) of
70 HI-1, six (9%) of 68 HI-2 and none of 87 H
patients admitted to the study developed peripheral
neuritis (Devadatta et al., 1960; Tuberculosis Chemo-
therapy Centre, 1960). Considering the 57 patients
referred to in Table 3, two (one slow and one rapid
inactivator of isoniazid) of the five PH patients had
the prescribed chemotherapy for the whole of the
second year, as did five (two slow and three rapid) of
the 12 HI-1, seven (three slow and four rapid) of the
11 HI-2 and 10 (four slow and six rapid) of the 29 H
patie ts. The durations of the prescribed chemo-
therapy in the remaining patients can be seen by
reference to the last column of Table 3. There were   
no ca es of peripheral neuritis during the second
year among these 57 patients or in the four patients
excluded from the main analysis, but one patient
(HI-l), a slow inactivator, whose symptoms com-
menced in the eighth month of treatment was diag-
nosed by an independent assessor at the end of the
sixteenth month of treatment as having peripheral
neuritis.
DISCUSSION
An earlier report from the Centre (Tuberculosisof bacteriological quiescence, to any of the three re-
Chemotherapy Centre, 1960) demonstrated that thegimens of isoniazid alone-namely, a moderate daily
combination of isoniazid plus PAS (the PH regimen)dosage (approximately 7.8-9.6 mg/kg) in one dose
was substantially superior, in terms of the attainmenta day (the HI-l regimen); the same moderate daily
dosage in two doses a day (the HI-2 regimen); and
a small daily dosage (approximately 3.9-5.5 mg/kg)
in two doses a day (the H regimen). Thus, at one
year 91% of 86 PH patients, as compared with 73 %
of 64 HI-1, 58 % of 66 HI-2, and 44 % of 86 H
patients, had bacteriologically quiescent disease or
disease of doubtful bacteriological status which has
since also been shown to be quiescent disease (Velu
et al., 1961). The proportions of patients who died
of tuberculosis or who had had their chemotherapy
changed during the first year because of a clear-cut
deterioration (radiographic in all except two cases)
were 2% for the PH, 8 % for the HI-1, 23 % for the
HI-2 and 21% for the H series. The HI-2 and H
regimens were, therefore, clearly unsatisfactory in
comparison with the PH regimen. The HI-1 series,
on the other hand, although substantially inferior to
the PH series in terms of the proportion of patients
excreting tubercle bacilli (27%, as compared with
8%) showed a comparatively minor difference in
terms of patients who had died or deteriorated and
had their treatment changed (8 %, as compared with
2%). It is well established that isoniazid-resistant
tubercle bacilli may have lowered virulence in the
guinea-pig (Barnett, Bushby & Mitchison, 1953;
Middlebrook & Cohn, 1953; Peizer, Widelock &
Klein, 1953; Morse et al., 1954). A number of
authorities consider that this applies in man also, and
that the emergence of isoniazid-resistant strains dur-
ing treatment, associated with persisting bacterio-
logical positivity, is not necessarily a serious event
(Deuschle et al., 1954; Middlebrook & Dressler,
1954; Oestreicher et al., 1955; McDermott, 1960).
The relative merits of the PH and HI-1 regimens
could therefore only be finally assessed by continuing
the initially prescribed chemotherapy for the second
year for the patients who had active disease at one
year with resistant tubercle bacilli and establishing
what course the disease followed. If the disease
attained bacteriological quiescence, this would be
evidence that bacteriological positivity with isoniazid-
resistant organisms at one year was not a harmful
state. Consequently the HI-1 regimen would approxi-
mate more closely to the PH regimen in efficacy. If
however, the patients continued to remain bacterio-
logically positive and a substantial proportion had
serious radiographic deterioration, then the danger
of persisting bacteriological positivity would be
established. Further information could be obtained
on the general risk of persisting bacteriological
positivity with isoniazid-resistant organisms by
studying the HI-2 and H regimens and seeing whether
the patients on them moved to bacteriologically
quiescent disease or to radiographic deterioration in
the second year.
In assessing the risk of bacteriological positivity
with isoniazid-resistant organisms, it was necessary
to take into account the observations of Oestreicher
et al. (1955) that radiographic spreads which occur in
patients undergoing treatment with isoniazid alone
frequently resolve without a change of chemo-
therapy. A procedure of independent assessment was
therefore followed, and the assessor reported a
patient as needing a change of chemotherapy when he
was satisfied that the radiographic progression of the
disease was not of the type reported by Oestreicher
et al. (1955).During the second year, three of six PH
patients, seven of 12 HI-1, four of 13 HI-2 and 19 of
30 H patients–that is, 33 of 61 patients-had a
radiographic deterioration warranting a change of
treatment. (These figures include the three patients
who received a low dosage of isoniazid or a placebo
in the second year and did not deteriorate, and the
patient who died of cor pulmonale.) The amalgam-
ated findings for tuberculous deaths and deteriora-
tions in the 2-year period in the patients whilst on
their initially prescribed chemotherapy consequently
increased to five (6 %) of 86 PH, 12 (19 %) of 64 HI-1,
19 (29 %) of 66 HI-2 and 37 (43 %) of 86 H patients.
Only nine of the 57 patients who continued on
their originally prescribed chemotherapy in the
second year attained bacteriologically quiescent
disease; six had yielded the last positive culture
towards the end of the first year, the remaining three
doing so at the twelfth or thirteenth month. Not one
patient who was bacteriologically positive at fourteen
months subsequently attained bacteriological quies-
cence. Of the 57 patients, no less than 33 had a
radiographic deterioration warranting a change of
chemotherapy. Thus, a clear picture emerged–
namely, that bacteriological positivity with isoniazid-
resistant organisms at one year, irrespective of their
level of resistance to isoniazid or their catalase
activity, was in nearly all instances followed by
deterioration in the second year or persisting positi-
vity at two years. It is therefore reasonable to
assume that the persisting positivity at two years
would also eventually lead to deterioration.
The only assessments at one year which were
rel ted to the therapeutic response in the second year
were the extent of cavitation and the degree of
culture-positivity. Of the nine patients who attained
bacteriological quiescence, eight had very low
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culture-positivity scores (six having just started the
period of bacteriological quiescence towards the end
of the first year) and six had no cavitation at the end
of the first year. However, it was not possible to
forecast with any degree of certainty which of the
patients who remained bacteriologically positive
after one year’s treatment would attain bacterio-
logical quiescence during the second year of treat-
ment, for only six of the 12 patients who had both
very low positivity scores and no cavitation attained
bacteriological quiescence.
Detailed analyses did not demonstrate any clear
evidence of an association between the response to
treatment in the second year and the level of isonia-
zid-resistance, the catalase activity, the susceptibility
to hydrogen peroxide or the degree of virulence in the
guinea-pig of cultures isolated at the end of the first
year. It will be appreciated that the population of
patients studied in this report is a selected one and
that a number of patients who died or who deterio-
rated radiographically and had their treatment
changed in the first year do not appear in the ana-
lysis; nor do patients who yielded isoniazid-resistant
strains in the first year and then attained bacterio-
logical quiescence before the end of the year. The
conclusions as to the influence of virulence, the
d gree of isoniazid-resistance, the catalase activity
and hy rogen peroxide susceptibility may not neces-
sarily apply to the full population of patients admit-
ted to the study or to the influence of these factors
in the first year. A further report will be published
on th  characteristics of the isoniazid-resistant
organisms isolated during the first year and their
influ nce on the response of the patients.
It may be concluded that persisting bacteriological
positivity at the end of one year’s treatment, even if
the patient is excreting highly isoniazid-resistant,
cata ase-negative tubercle bacilli, is likely to lead to
serious radiographic deterioration. This finding is in
clear contradistinction to those of Oestreicher et al.
(1955). The finding that isoniazid-resistant infec-  
tions are not self-limiting has considerable implica-
tions for mass therapy in developing countries. If
such therapy is with isoniazid alone it is very likely
that many cases with drug-resistant infections will be
produced and that the disease in these patients will
follow a deteriorating course. This observation
underlines the importance of the use, whenever pos-
sible, of effective combined chemotherapy and of the
need for finding effective, inexpensive and acceptable
alternative regimens for the treatment of pulmonary
tuberculosis.
SUMMARY
1. Of the 315 patients in the main analysis of awhich, in the opinion of an independent assessor,
controlled comparison of isoniazid plus PAS withwarranted a change of treatment.
three regimens of isoniazid alone, 61 had bacterio-3. The response to treatment in the second year
logically active or relapsed disease with isoniazid-was similar in each of the four treatment series.
resistant organisms at the end of the first year of4. There was an association between the response
treatment. This paper has presented the results of a
study of the response to treatment in the second year
to treatment in the second year and both the extent
of these 61 patients, 57 of whom continued on their
of cavitation and the degree of culture-positivity at
originally allocated treatment (five on isoniazid
the end of the first year. Patients with no cavitation
4.5 mg/kg plus PAS 0.23 g/kg daily, divided into
or whose specimens were weakly positive on culture
two doses; 12 on isoniazid 8.7 mg/kg daily, in one
more frequently attained bacteriological quiescence
dose; 11 on isoniazid 8.7 mg/kg daily, divided into
and, conversely, patients with cavitation or with
two doses; and 29 on isoniazid 4.5 mg/kg daily,
heavily positive cultures more frequently deterio-
divided into two doses). The study was undertaken
rated radiographically. However, six of the nine
in order to determine the prognosis of persisting
patients who achieved bacteriological quiescence had
bacteriological positivity at one year with isoniazid-
already commenced the period of persisting bacterio-
resistant tubercle bacilli.
logical negativity in the first year; the other three
did so before 14 months.
2. Of the 57 patients, nine (16 %) attained bacterio-5. There was no clear association between res-
logical quiescence, 15 (26%) had bacteriologicallyponse to treatment in the second year and the num-
active disease at the end of the second year and 33ber of lung zones involved in disease, the total
(58 %) had had a serious radiographic deteriorationadiographic extent of the lesion, the level of resist-
COURSE OF TUBERCULOSIS IN PATIENTS WITH ISONIAZID-RESISTANT ORGANISMS 17
ance to isoniazid according to two definitions, thement with isoniazid, alone or in combination with
catalase activity, the susceptibility to hydrogen per-PAS, is likely to deteriorate irrespective of the level
oxide or the virulence in the guinea-pig of culturesof resistance to isoniazid or of the catalase activity of
isolated in the last months of the first year. the cultures of tubercle bacilli. The object of treat-
6. It is concluded that the disease in patients withment of patients with bacteriologically positive pul-
persisting bacteriological positivity with isoniazid-monary tuberculosis must therefore be to render the
resistant organisms at the end of one year of treat-sputum culture-negative in all instances.
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